The capacity of PGD2 generated by S. mansoni adult worms to induce the synthesis of a major profibrotic mediator supplied the rationale to target PGD2 as a potential therapy in parasitic diseases (Magalhaes et al., 2019). Here, HPGDS is linked to parasitic infectious disease.